Table of Content

1 Study Coverage
1.1 Neurological Biomarkers Product Introduction
1.2 Market by Type
1.2.1 Global Neurological Biomarkers Market Size Growth Rate by Type
1.4.2 Proteomics
1.4.3 Genomics
1.2.4 Imaging
1.2.5 Bioinformatics
1.2.6 Others
1.3 Market by Application
1.3.1 Global Neurological Biomarkers Market Size Growth Rate by Application
1.3.2 Diagnostics
1.3.3 Drug Discovery
1.3.4 Personalized Medicine
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered

2 Executive Summary
2.1 Global Neurological Biomarkers Sales Estimates and Forecasts 2016-2027
2.2 Global Neurological Biomarkers Revenue Estimates and Forecasts 2016-2027
2.3 Global Neurological Biomarkers Revenue by Region: 2016 VS 2021 VS 2027
2.4 Global Top Neurological Biomarkers Regions by Sales
2.4.1 Global Top Neurological Biomarkers Regions by Sales (2016-2021)
2.4.2 Global Top Neurological Biomarkers Regions by Sales (2022-2027)
2.5 Global Top Neurological Biomarkers Regions by Revenue
2.5.1 Global Top Neurological Biomarkers Regions by Revenue (2016-2021)
2.5.2 Global Top Neurological Biomarkers Regions by Revenue (2022-2027)
2.6 North America
2.7 Europe
2.8 Asia-Pacific
2.9 Latin America
2.10 Middle East & Africa
3 Competition by Manufacturers
3.1 Global Neurological Biomarkers Sales by Manufacturers
3.1.1 Global Top Neurological Biomarkers Manufacturers by Sales (2016-2021)
3.1.2 Global Top Neurological Biomarkers Manufacturers Market Share by Sales (2016-2021)
3.1.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Sales in 2020
3.2 Global Neurological Biomarkers Revenue by Manufacturers
3.2.1 Global Top Neurological Biomarkers Manufacturers by Revenue (2016-2021)
3.2.2 Global Top Neurological Biomarkers Manufacturers Market Share by Revenue (2016-2021)
3.2.3 Global Top 10 and Top 5 Companies by Neurological Biomarkers Revenue in 2020
3.3 Global Neurological Biomarkers Sales Price by Manufacturers
3.4 Analysis of Competitive Landscape
3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4.3 Global Neurological Biomarkers Manufacturers Geographical Distribution
3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Neurological Biomarkers Sales by Type
4.1.1 Global Neurological Biomarkers Historical Sales by Type (2016-2021)
4.1.2 Global Neurological Biomarkers Forecasted Sales by Type (2022-2027)
4.1.3 Global Neurological Biomarkers Sales Market Share by Type (2016-2027)
4.2 Global Neurological Biomarkers Revenue by Type
4.2.1 Global Neurological Biomarkers Historical Revenue by Type (2016-2021)
4.2.2 Global Neurological Biomarkers Forecasted Revenue by Type (2022-2027)
4.2.3 Global Neurological Biomarkers Revenue Market Share by Type (2016-2027)
4.3 Global Neurological Biomarkers Price by Type
4.3.1 Global Neurological Biomarkers Price by Type (2016-2021)
4.3.2 Global Neurological Biomarkers Price Forecast by Type (2022-2027)
5 Market Size by Application
5.1 Global Neurological Biomarkers Sales by Application
5.1.1 Global Neurological Biomarkers Historical Sales by Application (2016-2021)
5.1.2 Global Neurological Biomarkers Forecasted Sales by Application (2022-2027)
5.1.3 Global Neurological Biomarkers Sales Market Share by Application (2016-2027)
5.2 Global Neurological Biomarkers Revenue by Application
5.2.1 Global Neurological Biomarkers Historical Revenue by Application (2016-2021)
5.2.2 Global Neurological Biomarkers Forecasted Revenue by Application (2022-2027)
5.2.3 Global Neurological Biomarkers Revenue Market Share by Application (2016-2027)
5.3 Global Neurological Biomarkers Price by Application
5.3.1 Global Neurological Biomarkers Price by Application (2016-2021)
5.3.2 Global Neurological Biomarkers Price Forecast by Application (2022-2027)

6 North America
6.1 North America Neurological Biomarkers Market Size by Type
6.1.1 North America Neurological Biomarkers Sales by Type (2016-2027)
6.1.2 North America Neurological Biomarkers Revenue by Type (2016-2027)
6.2 North America Neurological Biomarkers Market Size by Application
6.2.1 North America Neurological Biomarkers Sales by Application (2016-2027)
6.2.2 North America Neurological Biomarkers Revenue by Application (2016-2027)
6.3 North America Neurological Biomarkers Market Size by Country
6.3.1 North America Neurological Biomarkers Sales by Country (2016-2027)
6.3.2 North America Neurological Biomarkers Revenue by Country (2016-2027)
6.3.3 U.S.
6.3.4 Canada
7 Europe
7.1 Europe Neurological Biomarkers Market Size by Type
7.1.1 Europe Neurological Biomarkers Sales by Type (2017-2027)
7.1.2 Europe Neurological Biomarkers Revenue by Type (2017-2027)
7.2 Europe Neurological Biomarkers Market Size by Application
7.2.1 Europe Neurological Biomarkers Sales by Application (2017-2027)
7.2.2 Europe Neurological Biomarkers Revenue by Application (2017-2027)
7.3 Europe Neurological Biomarkers Market Size by Country
7.3.1 Europe Neurological Biomarkers Sales by Country (2017-2027)
7.3.2 Europe Neurological Biomarkers Revenue by Country (2017-2027)
7.3.3 Germany
7.3.4 France
7.3.5 U.K.
7.3.6 Italy
7.3.7 Russia
8 Asia Pacific
8.1 Asia Pacific Neurological Biomarkers Market Size by Type
8.1.1 Asia Pacific Neurological Biomarkers Sales by Type (2018-2027)
8.1.2 Asia Pacific Neurological Biomarkers Revenue by Type (2018-2027)
8.2 Asia Pacific Neurological Biomarkers Market Size by Application
8.2.1 Asia Pacific Neurological Biomarkers Sales by Application (2018-2027)
8.2.2 Asia Pacific Neurological Biomarkers Revenue by Application (2018-2027)
8.3 Asia Pacific Neurological Biomarkers Market Size by Region
8.3.1 Asia Pacific Neurological Biomarkers Sales by Region (2018-2027)
8.3.2 Asia Pacific Neurological Biomarkers Revenue by Region (2018-2027)
8.3.3 China
8.3.4 Japan
8.3.5 South Korea
8.3.6 India
8.3.7 Australia
8.3.8 Taiwan
8.3.9 Indonesia
8.3.10 Thailand
8.3.11 Malaysia
8.3.12 Philippines
9 Latin America
9.1 Latin America Neurological Biomarkers Market Size by Type
9.1.1 Latin America Neurological Biomarkers Sales by Type (2019-2027)
9.1.2 Latin America Neurological Biomarkers Revenue by Type (2019-2027)
9.2 Latin America Neurological Biomarkers Market Size by Application
9.2.1 Latin America Neurological Biomarkers Sales by Application (2019-2027)
9.2.2 Latin America Neurological Biomarkers Revenue by Application (2019-2027)
9.3 Latin America Neurological Biomarkers Market Size by Country
9.3.1 Latin America Neurological Biomarkers Sales by Country (2019-2027)
9.3.2 Latin America Neurological Biomarkers Revenue by Country (2019-2027)
9.3.3 Mexico
9.3.4 Brazil
9.3.5 Argentina
6 Middle East and Africa
6.1 Middle East and Africa Neurological Biomarkers Market Size by Type
6.1.1 Middle East and Africa Neurological Biomarkers Sales by Type (2016-2027)
6.1.2 Middle East and Africa Neurological Biomarkers Revenue by Type (2016-2027)
6.2 Middle East and Africa Neurological Biomarkers Market Size by Application
6.2.1 Middle East and Africa Neurological Biomarkers Sales by Application (2016-2027)
6.2.2 Middle East and Africa Neurological Biomarkers Revenue by Application (2016-2027)
6.3 Middle East and Africa Neurological Biomarkers Market Size by Country
6.3.1 Middle East and Africa Neurological Biomarkers Sales by Country (2016-2027)
6.3.2 Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2027)
6.3.3 Turkey
6.3.4 Saudi Arabia
6.3.5 U.A.E

11 Company Profiles
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Description
11.1.5 Thermo Fisher Scientific Related Developments
11.2 Merck
11.2.1 Merck Corporation Information
11.2.2 Merck Overview
11.2.3 Merck Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.2.4 Merck Neurological Biomarkers Product Description
11.2.5 Merck Related Developments
11.3 Quest Diagnostics
11.3.1 Quest Diagnostics Corporation Information
11.3.2 Quest Diagnostics Overview
11.3.3 Quest Diagnostics Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.3.4 Quest Diagnostics Neurological Biomarkers Product Description
11.3.5 Quest Diagnostics Related Developments
11.4 Abbott
11.4.1 Abbott Corporation Information
11.4.2 Abbott Overview
11.4.3 Abbott Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.4.4 Abbott Neurological Biomarkers Product Description
11.4.5 Abbott Related Developments
11.5 Roche
11.5.1 Roche Corporation Information
11.5.2 Roche Overview
11.5.3 Roche Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.5.4 Roche Neurological Biomarkers Product Description
11.5.5 Roche Related Developments
11.6 Illumina
11.6.1 Illumina Corporation Information
11.6.2 Illumina Overview
11.6.3 Illumina Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.6.4 Illumina Neurological Biomarkers Product Description
11.6.5 Illumina Related Developments
11.7 Bio-Rad Laboratories
11.7.1 Bio-Rad Laboratories Corporation Information
11.7.2 Bio-Rad Laboratories Overview
11.7.3 Bio-Rad Laboratories Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.7.4 Bio-Rad Laboratories Neurological Biomarkers Product Description
11.7.5 Bio-Rad Laboratories Related Developments
11.8 QIAGEN
11.8.1 QIAGEN Corporation Information
11.8.2 QIAGEN Overview
11.8.3 QIAGEN Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.8.4 QIAGEN Neurological Biomarkers Product Description
11.8.5 QIAGEN Related Developments
11.9 Myriad RBM
11.9.1 Myriad RBM Corporation Information
11.9.2 Myriad RBM Overview
11.9.3 Myriad RBM Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.9.4 Myriad RBM Neurological Biomarkers Product Description
11.9.5 Myriad RBM Related Developments
11.10 Cisbio Bioassays
11.10.1 Cisbio Bioassays Corporation Information
11.10.2 Cisbio Bioassays Overview
11.10.3 Cisbio Bioassays Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.10.4 Cisbio Bioassays Neurological Biomarkers Product Description
11.10.5 Cisbio Bioassays Related Developments
11.1 Thermo Fisher Scientific
11.1.1 Thermo Fisher Scientific Corporation Information
11.1.2 Thermo Fisher Scientific Overview
11.1.3 Thermo Fisher Scientific Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.1.4 Thermo Fisher Scientific Neurological Biomarkers Product Description
11.1.5 Thermo Fisher Scientific Related Developments
11.12 BGI
11.12.1 BGI Corporation Information
11.12.2 BGI Overview
11.12.3 BGI Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.12.4 BGI Product Description
11.12.5 BGI Related Developments
11.13 Wuxi APP
11.13.1 Wuxi APP Corporation Information
11.13.2 Wuxi APP Overview
11.13.3 Wuxi APP Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.13.4 Wuxi APP Product Description
11.13.5 Wuxi APP Related Developments
11.14 Aepodia
11.14.1 Aepodia Corporation Information
11.14.2 Aepodia Overview
11.14.3 Aepodia Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.14.4 Aepodia Product Description
11.14.5 Aepodia Related Developments
11.15 Proteome Sciences
11.15.1 Proteome Sciences Corporation Information
11.15.2 Proteome Sciences Overview
11.15.3 Proteome Sciences Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.15.4 Proteome Sciences Product Description
11.15.5 Proteome Sciences Related Developments
11.16 Genewiz
11.16.1 Genewiz Corporation Information
11.16.2 Genewiz Overview
11.16.3 Genewiz Neurological Biomarkers Sales, Price, Revenue and Gross Margin (2016-2021)
11.16.4 Genewiz Product Description
11.16.5 Genewiz Related Developments

12 Value Chain and Sales Channels Analysis
12.1 Neurological Biomarkers Value Chain Analysis
12.2 Neurological Biomarkers Key Raw Materials
12.2.1 Key Raw Materials
12.2.2 Raw Materials Key Suppliers
12.3 Neurological Biomarkers Production Mode & Process
12.4 Neurological Biomarkers Sales and Marketing
12.4.1 Neurological Biomarkers Sales Channels
12.4.2 Neurological Biomarkers Distributors
12.5 Neurological Biomarkers Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
13.1 Neurological Biomarkers Industry Trends
13.2 Neurological Biomarkers Market Drivers
13.3 Neurological Biomarkers Market Challenges
13.4 Neurological Biomarkers Market Restraints

14 Key Findings in The Global Neurological Biomarkers Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Figure

List of Tables
Table 1. Global Neurological Biomarkers Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of Proteomics
Table 3. Major Manufacturers of Genomics
Table 4. Major Manufacturers of Imaging
Table 5. Major Manufacturers of Bioinformatics
Table 6. Major Manufacturers of Others
Table 7. Global Neurological Biomarkers Market Size Growth Rate by Application, 2016 VS 2021 VS 2027 (US$ Million)
Table 8. Global Neurological Biomarkers Revenue by Region: 2016 VS 2021 VS 2027 (US$ Million)
Table 9. Global Neurological Biomarkers Sales by Region (2016-2021) & (K Units)
Table 10. Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
Table 11. Global Neurological Biomarkers Sales by Region (2016-2021) & (K Units)
Table 12. Global Neurological Biomarkers Sales Market Share by Region (2022-2027)
Table 13. Global Neurological Biomarkers Revenue by Region (2016-2021) & (US$ Million)
Table 14. Global Neurological Biomarkers Revenue Market Share by Region (2016-2021)
Table 15. Global Neurological Biomarkers Revenue by Region (2022-2027) & (US$ Million)
Table 16. Global Neurological Biomarkers Revenue Market Share by Region (2022-2027)
Table 17. Global Neurological Biomarkers Sales by Manufacturers (2016-2021) & (K Units)
Table 18. Global Neurological Biomarkers Sales Share by Manufacturers (2016-2021)
Table 19. Global Neurological Biomarkers Revenue by Manufacturers (2016-2021) & (US$ Million)
Table 20. Global Neurological Biomarkers Revenue Share by Manufacturers (2016-2021)
Table 21. Neurological Biomarkers Price by Manufacturers 2016-2021 (USD/Unit)
Table 22. Global Neurological Biomarkers Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 23. Global Neurological Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Neurological Biomarkers as of 2020)
Table 24. Neurological Biomarkers Manufacturing Base Distribution and Headquarters
Table 25. Manufacturers Neurological Biomarkers Product Offered
Table 26. Date of Manufacturers Enter into Neurological Biomarkers Market
Table 27. Mergers & Acquisitions, Expansion Plans
Table 28. Global Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 29. Global Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 30. Global Neurological Biomarkers Sales Share by Type (2016-2021)
Table 31. Global Neurological Biomarkers Sales Share by Type (2022-2027)
Table 32. Global Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 33. Global Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million)
Table 34. Global Neurological Biomarkers Revenue Share by Type (2016-2021)
Table 35. Global Neurological Biomarkers Revenue Share by Type (2022-2027)
Table 36. Neurological Biomarkers Price by Type (2016-2021) & (USD/Unit)
Table 37. Global Neurological Biomarkers Price Forecast by Type (2022-2027) & (USD/Unit)
Table 38. Global Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 39. Global Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 40. Global Neurological Biomarkers Sales Share by Application (2016-2021)
Table 41. Global Neurological Biomarkers Sales Share by Application (2022-2027)
Table 42. Global Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 43. Global Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million)
Table 44. Global Neurological Biomarkers Revenue Share by Application (2016-2021)
Table 45. Global Neurological Biomarkers Revenue Share by Application (2022-2027)
Table 46. Neurological Biomarkers Price by Application (2016-2021) & (USD/Unit)
Table 47. Global Neurological Biomarkers Price Forecast by Application (2022-2027) & (USD/Unit)
Table 48. North America Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 49. North America Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 50. North America Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 51. North America Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million)
Table 52. North America Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 53. North America Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 54. North America Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 55. North America Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million)
Table 56. North America Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 57. North America Neurological Biomarkers Sales by Country (2022-2027) & (K Units)
Table 58. North America Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 59. North America Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million)
Table 60. Europe Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 61. Europe Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 62. Europe Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 63. Europe Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million)
Table 64. Europe Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 65. Europe Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 66. Europe Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 67. Europe Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million)
Table 68. Europe Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 69. Europe Neurological Biomarkers Sales by Country (2022-2027) & (K Units)
Table 70. Europe Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 71. Europe Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million)
Table 72. Asia Pacific Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 73. Asia Pacific Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 74. Asia Pacific Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 75. Asia Pacific Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million)
Table 76. Asia Pacific Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 77. Asia Pacific Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 78. Asia Pacific Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 79. Asia Pacific Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million)
Table 80. Asia Pacific Neurological Biomarkers Sales by Region (2016-2021) & (K Units)
Table 81. Asia Pacific Neurological Biomarkers Sales by Region (2022-2027) & (K Units)
Table 82. Asia Pacific Neurological Biomarkers Revenue by Region (2016-2021) & (US$ Million)
Table 83. Asia Pacific Neurological Biomarkers Revenue by Region (2022-2027) & (US$ Million)
Table 84. Latin America Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 85. Latin America Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 86. Latin America Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 87. Latin America Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million)
Table 88. Latin America Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 89. Latin America Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 90. Latin America Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 91. Latin America Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million)
Table 92. Latin America Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 93. Latin America Neurological Biomarkers Sales by Country (2022-2027) & (K Units)
Table 94. Latin America Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 95. Latin America Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million)
Table 96. Middle East and Africa Neurological Biomarkers Sales by Type (2016-2021) & (K Units)
Table 97. Middle East and Africa Neurological Biomarkers Sales by Type (2022-2027) & (K Units)
Table 98. Middle East and Africa Neurological Biomarkers Revenue by Type (2016-2021) & (US$ Million)
Table 99. Middle East and Africa Neurological Biomarkers Revenue by Type (2022-2027) & (US$ Million)
Table 100. Middle East and Africa Neurological Biomarkers Sales by Application (2016-2021) & (K Units)
Table 101. Middle East and Africa Neurological Biomarkers Sales by Application (2022-2027) & (K Units)
Table 102. Middle East and Africa Neurological Biomarkers Revenue by Application (2016-2021) & (US$ Million)
Table 103. Middle East and Africa Neurological Biomarkers Revenue by Application (2022-2027) & (US$ Million)
Table 104. Middle East and Africa Neurological Biomarkers Sales by Country (2016-2021) & (K Units)
Table 105. Middle East and Africa Neurological Biomarkers Sales by Country (2022-2027) & (K Units)
Table 106. Middle East and Africa Neurological Biomarkers Revenue by Country (2016-2021) & (US$ Million)
Table 107. Middle East and Africa Neurological Biomarkers Revenue by Country (2022-2027) & (US$ Million)
Table 108. Thermo Fisher Scientific Corporation Information
Table 109. Thermo Fisher Scientific Description and Major Businesses
Table 110. Thermo Fisher Scientific Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 111. Thermo Fisher Scientific Neurological Biomarkers Product
Table 112. Thermo Fisher Scientific Recent Developments
Table 113. Merck Corporation Information
Table 114. Merck Description and Major Businesses
Table 115. Merck Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 116. Merck Neurological Biomarkers Product
Table 117. Merck Recent Developments
Table 118. Quest Diagnostics Corporation Information
Table 119. Quest Diagnostics Description and Major Businesses
Table 120. Quest Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 121. Quest Diagnostics Neurological Biomarkers Product
Table 122. Quest Diagnostics Recent Developments
Table 123. Abbott Corporation Information
Table 124. Abbott Description and Major Businesses
Table 125. Abbott Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 126. Abbott Neurological Biomarkers Product
Table 127. Abbott Recent Developments
Table 128. Roche Corporation Information
Table 129. Roche Description and Major Businesses
Table 130. Roche Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 131. Roche Neurological Biomarkers Product
Table 132. Roche Recent Developments
Table 133. Illumina Corporation Information
Table 134. Illumina Description and Major Businesses
Table 135. Illumina Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 136. Illumina Neurological Biomarkers Product
Table 137. Illumina Recent Developments
Table 138. Bio-Rad Laboratories Corporation Information
Table 139. Bio-Rad Laboratories Description and Major Businesses
Table 140. Bio-Rad Laboratories Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 141. Bio-Rad Laboratories Neurological Biomarkers Product
Table 142. Bio-Rad Laboratories Recent Developments
Table 143. QIAGEN Corporation Information
Table 144. QIAGEN Description and Major Businesses
Table 145. QIAGEN Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 146. QIAGEN Neurological Biomarkers Product
Table 147. QIAGEN Recent Developments
Table 148. Myriad RBM Corporation Information
Table 149. Myriad RBM Description and Major Businesses
Table 150. Myriad RBM Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 151. Myriad RBM Neurological Biomarkers Product
Table 152. Myriad RBM Recent Developments
Table 153. Cisbio Bioassays Corporation Information
Table 154. Cisbio Bioassays Description and Major Businesses
Table 155. Cisbio Bioassays Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 156. Cisbio Bioassays Neurological Biomarkers Product
Table 157. Cisbio Bioassays Recent Developments
Table 158. Athena Diagnostics Corporation Information
Table 159. Athena Diagnostics Description and Major Businesses
Table 160. Athena Diagnostics Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 161. Athena Diagnostics Neurological Biomarkers Product
Table 162. Athena Diagnostics Recent Developments
Table 163. BGI Corporation Information
Table 164. BGI Description and Major Businesses
Table 165. BGI Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 166. BGI Neurological Biomarkers Product
Table 167. BGI Recent Developments
Table 168. Wuxi APP Corporation Information
Table 169. Wuxi APP Description and Major Businesses
Table 170. Wuxi APP Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 171. Wuxi APP Neurological Biomarkers Product
Table 172. Wuxi APP Recent Developments
Table 173. Aepodia Corporation Information
Table 174. Aepodia Description and Major Businesses
Table 175. Aepodia Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 176. Aepodia Neurological Biomarkers Product
Table 177. Aepodia Recent Developments
Table 178. Proteome Sciences Corporation Information
Table 179. Proteome Sciences Description and Major Businesses
Table 180. Proteome Sciences Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 181. Proteome Sciences Neurological Biomarkers Product
Table 182. Proteome Sciences Recent Developments
Table 183. Genewiz Corporation Information
Table 184. Genewiz Description and Major Businesses
Table 185. Genewiz Neurological Biomarkers Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 186. Genewiz Neurological Biomarkers Product
Table 187. Genewiz Recent Developments
Table 188. Key Raw Materials Lists
Table 189. Raw Materials Key Suppliers Lists
Table 190. Neurological Biomarkers Distributors List
Table 191. Neurological Biomarkers Customers List
Table 192. Neurological Biomarkers Market Trends
Table 193. Neurological Biomarkers Market Drivers
Table 194. Neurological Biomarkers Market Challenges
Table 195. Neurological Biomarkers Market Restraints
Table 196. Research Programs/Design for This Report
Table 197. Key Data Information from Secondary Sources
Table 198. Key Data Information from Primary Sources
List of Figures
Figure 1. Neurological Biomarkers Product Picture
Figure 2. Global Neurological Biomarkers Market Share by Type in 2020 & 2027
Figure 3. Proteomics Product Picture
Figure 4. Genomics Product Picture
Figure 5. Imaging Product Picture
Figure 6. Bioinformatics Product Picture
Figure 7. Others Product Picture
Figure 8. Global Neurological Biomarkers Sales Market Share by Application in 2020 & 2027
Figure 9. Diagnostics
Figure 10. Drug Discovery
Figure 11. Personalized Medicine
Figure 12. Others
Figure 13. Neurological Biomarkers Report Years Considered
Figure 14. Global Neurological Biomarkers Sales 2016-2027 (K Units)
Figure 15. Global Neurological Biomarkers Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 16. Global Neurological Biomarkers Revenue 2016-2027 (US$ Million)
Figure 17. Global Neurological Biomarkers Revenue Market Share by Region in Percentage: 2020 Versus 2027
Figure 18. Global Neurological Biomarkers Sales Market Share by Region (2016-2021)
Figure 19. Global Neurological Biomarkers Sales Market Share by Region (2022-2027)
Figure 20. North America Neurological Biomarkers Sales YoY (2016-2027) & (K Units)
Figure 21. North America Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million)
Figure 22. Europe Neurological Biomarkers Sales YoY (2016-2027) & (K Units)
Figure 23. Europe Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million)
Figure 24. Asia-Pacific Neurological Biomarkers Sales YoY (2016-2027) & (K Units)
Figure 25. Asia-Pacific Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million)
Figure 26. Latin America Neurological Biomarkers Sales YoY (2016-2027) & (K Units)
Figure 27. Latin America Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million)
Figure 28. Middle East & Africa Neurological Biomarkers Sales YoY (2016-2027) & (K Units)
Figure 29. Middle East & Africa Neurological Biomarkers Revenue YoY (2016-2027) & (US$ Million)
Figure 30. The Top 10 and Top 5 Players Market Share by Neurological Biomarkers Sales in 2020
Figure 31. The Top 10 and Top 5 Players Market Share by Neurological Biomarkers Revenue in 2020
Figure 32. Neurological Biomarkers Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2016 VS 2020
Figure 33. Global Neurological Biomarkers Sales Market Share by Type (2016-2027)
Figure 34. Global Neurological Biomarkers Revenue Market Share by Type (2016-2027)
Figure 35. Global Neurological Biomarkers Sales Market Share by Application (2016-2027)
Figure 36. Global Neurological Biomarkers Revenue Market Share by Application (2016-2027)
Figure 37. North America Neurological Biomarkers Sales Market Share by Type (2016-2027)
Figure 38. North America Neurological Biomarkers Revenue Market Share by Type (2016-2027)
Figure 39. North America Neurological Biomarkers Sales Market Share by Application (2016-2027)
Figure 40. North America Neurological Biomarkers Revenue Market Share by Application (2016-2027)
Figure 41. North America Neurological Biomarkers Sales Share by Country (2016-2027)
Figure 42. North America Neurological Biomarkers Revenue Share by Country (2016-2027)
Figure 43. U.S. Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 44. Canada Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 45. Europe Neurological Biomarkers Sales Market Share by Type (2016-2027)
Figure 46. Europe Neurological Biomarkers Revenue Market Share by Type (2016-2027)
Figure 47. Europe Neurological Biomarkers Sales Market Share by Application (2016-2027)
Figure 48. Europe Neurological Biomarkers Revenue Market Share by Application (2016-2027)
Figure 49. Europe Neurological Biomarkers Sales Share by Country (2016-2027)
Figure 50. Europe Neurological Biomarkers Revenue Share by Country (2016-2027)
Figure 51. Germany Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 52. France Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 53. U.K. Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 54. Italy Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 55. Russia Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 56. Asia Pacific Neurological Biomarkers Sales Market Share by Type (2016-2027)
Figure 57. Asia Pacific Neurological Biomarkers Revenue Market Share by Type (2016-2027)
Figure 58. Asia Pacific Neurological Biomarkers Sales Market Share by Application (2016-2027)
Figure 59. Asia Pacific Neurological Biomarkers Revenue Market Share by Application (2016-2027)
Figure 60. Asia Pacific Neurological Biomarkers Sales Share by Region (2016-2027)
Figure 61. Asia Pacific Neurological Biomarkers Revenue Share by Region (2016-2027)
Figure 62. China Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 63. Japan Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 64. South Korea Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 65. India Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 66. Australia Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 67. Taiwan Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 68. Indonesia Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 69. Thailand Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 70. Malaysia Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 71. Philippines Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 72. Latin America Neurological Biomarkers Sales Market Share by Type (2016-2027)
Figure 73. Latin America Neurological Biomarkers Revenue Market Share by Type (2016-2027)
Figure 74. Latin America Neurological Biomarkers Sales Market Share by Application (2016-2027)
Figure 75. Latin America Neurological Biomarkers Revenue Market Share by Application (2016-2027)
Figure 76. Latin America Neurological Biomarkers Sales Share by Country (2016-2027)
Figure 77. Latin America Neurological Biomarkers Revenue Share by Country (2016-2027)
Figure 78. Mexico Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 79. Brazil Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 80. Argentina Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 81. Middle East and Africa Neurological Biomarkers Sales Market Share by Type (2016-2027)
Figure 82. Middle East and Africa Neurological Biomarkers Revenue Market Share by Type (2016-2027)
Figure 83. Middle East and Africa Neurological Biomarkers Sales Market Share by Application (2016-2027)
Figure 84. Middle East and Africa Neurological Biomarkers Revenue Market Share by Application (2016-2027)
Figure 85. Middle East and Africa Neurological Biomarkers Sales Share by Country (2016-2027)
Figure 86. Middle East and Africa Neurological Biomarkers Revenue Share by Country (2016-2027)
Figure 87. Turkey Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 88. Saudi Arabia Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 89. U.A.E Neurological Biomarkers Revenue (2016-2027) & (US$ Million)
Figure 90. Neurological Biomarkers Value Chain
Figure 91. Neurological Biomarkers Production Process
Figure 92. Channels of Distribution
Figure 93. Distributors Profiles
Figure 94. Bottom-up and Top-down Approaches for This Report
Figure 95. Data Triangulation
Figure 96. Key Executives Interviewed